Showing results (411-420 of 511) with videos related to

Sort By:
Pageof 52
The New England Journal of Medicine|December 16, 2011
Liberal or restrictive transfusion in high-risk patients after hip surgeryJeffrey L Carson, Michael L Terrin, Helaine Noveck, et al.
JAMA|October 13, 2016
Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and StorageJeffrey L Carson, Gordon Guyatt, Nancy M Heddle, et al.
Acta Anaesthesiologica Scandinavica|May 17, 2022
Agents intervening against delirium in the intensive care unit trial-Protocol for a secondary Bayesian analysisNina Andersen-Ranberg, Lone M Poulsen, Anders Perner, et al.
Acta Anaesthesiologica Scandinavica|December 28, 2021
Development of a core outcome set for general intensive care unit patients-A protocolMaj-Brit Nørregaard Kjaer, Anders Granholm, Gitte Kingo Vesterlund, et al.
Intensive Care Medicine|September 5, 2024
Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemiaElena Crescioli, Frederik Mølgaard Nielsen, Anne-Marie Bunzel, et al.
American Heart Journal|January 18, 2025
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemiaGerard T Portela, Gregory Ducrocq, Marnie Bertolet, et al.
Annals of Internal Medicine|July 4, 2012
Red blood cell transfusion: a clinical practice guideline from the AABB*Jeffrey L Carson, Brenda J Grossman, Steven Kleinman, et al.
Intensive Care Medicine|July 21, 2017
The Intensive Care Medicine research agenda on critically ill oncology and hematology patientsElie Azoulay, Peter Schellongowski, Michael Darmon, et al.
NEJM Evidence|June 14, 2024
Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding - An Updated Meta-AnalysisYing Wang, Sameer Parpia, Long Ge, et al.
Annals of Intensive Care|July 15, 2025
Hyperglycemia and insulin use in patients with COVID-19 and severe hypoxemia allocated to 12 mg vs. 6 mg of dexamethasone: a secondary analysis of the COVID STEROID 2 randomized trialClara Lundetoft Clausen, Thomas Bryrup, Christian Leo Hansen, et al.
Pageof 52